^
Association details:
| Biomarker: | KRAS G12C |
|---|---|
| Cancer: | Rectal Cancer |
| Drug: | Vectibix (panitumumab) (EGFR inhibitor) + Krazati (adagrasib) (KRAS G12C inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/21/2023
Excerpt:
Rectal Cancer: SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE…Adagrasib + panitumumab (KRAS G12C mutation positive)…
